China Universal Asset Management Company’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.7K | Buy |
28,917
+466
| +2% | +$1.12K | 0.01% | 392 |
|
|
2025
Q1 | $62.9K | Sell |
28,451
-1,625
| -5% | -$3.59K | 0.01% | 396 |
|
|
2024
Q4 | $164K | Buy |
30,076
+2,851
| +10% | +$15.5K | 0.02% | 341 |
|
|
2024
Q3 | $226K | Buy |
27,225
+11,621
| +74% | +$96.6K | 0.02% | 293 |
|
|
2024
Q2 | $112K | Sell |
15,604
-9,830
| -39% | -$70.4K | 0.02% | 294 |
|
|
2024
Q1 | $221K | Buy |
25,434
+10,142
| +66% | +$87.9K | 0.03% | 277 |
|
|
2023
Q4 | $100K | Buy |
15,292
+11,901
| +351% | +$78K | 0.02% | 278 |
|
|
2023
Q3 | $33.9K | Buy |
3,391
+1,662
| +96% | +$16.6K | 0.01% | 256 |
|
|
2023
Q2 | $21.5K | Sell |
1,729
-57
| -3% | -$708 | 0.01% | 261 |
|
|
2023
Q1 | $25K | Buy |
1,786
+450
| +34% | +$6.31K | 0.01% | 200 |
|
|
2022
Q4 | $19.1K | Buy |
1,336
+104
| +8% | +$1.49K | 0.01% | 176 |
|
|
2022
Q3 | $31K | Buy |
+1,232
| New | +$31K | 0.01% | 138 |
|